The Commission sent warning letters to major pharmaceutical companies, including Teva, GSK, and AstraZeneca, challenging over 300 patent listings it deemed improper
Costa EK
A significant difference in patient behavior, based upon the average of investigator ratings on the SKAMP-Deportment scores across all 7 assessments conducted at 1.5, 2.5, 5.0, 7.5, 10.0, 12.0, and 13.0 hours post-dose, were observed between patients when they received VYVANSE compared to patients when they received placebo (Study 3 in Table 6, Figure 4)
QZ and SU were trained within of the PhD program Metabolic and Cardiovascular Disease (DK-MCD) and Biomolecular Structures and Interactions (BioMolStruct)
Lotan, R
Information here is reported for educational reference